7.5K(top 4%)
articles
396.6K(top 2%)
citations
1,867(top 3%)
★★ articles
73(top 3%)
★★★ articles
2.1(top 30%)
Avg IF
244(top 2%)
H-Index
429(top 2%)
G-Index
1,365
journals

Most Cited Articles of GlaxoSmithKline in 2011

TitleJournalYearCitations
Genetic variants in novel pathways influence blood pressure and cardiovascular disease riskNature20111.6K
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometryNature Protocols20111.5K
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitisCell20111.4K
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics20111.4K
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature20111.1K
Principles of early drug discoveryBritish Journal of Pharmacology20111.1K
Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery2011768
Expanding GSK's solvent selection guide – embedding sustainability into solvent selection starting at medicinal chemistryGreen Chemistry2011725
Case definition and phenotype standardization in drug-induced liver injuryClinical Pharmacology and Therapeutics2011563
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsArthritis and Rheumatism2011520
Using the Right Green Yardstick: Why Process Mass Intensity Is Used in the Pharmaceutical Industry To Drive More Sustainable ProcessesOrganic Process Research and Development2011456
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibitionClinical Cancer Research2011442
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasmaNature Genetics2011415
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202Journal of Infectious Diseases2011386
DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's diseaseNeuroImage2011381
Managing the challenge of chemically reactive metabolites in drug developmentNature Reviews Drug Discovery2011348
Basic statistical analysis in genetic case-control studiesNature Protocols2011344
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressureNature Genetics2011338
Epidemiology and etiology of denture stomatitisJournal of Prosthodontics2011333
A functional role for Nlrp6 in intestinal inflammation and tumorigenesisJournal of Immunology2011315
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomyNeuroImage2011308
Key Green Engineering Research Areas for Sustainable Manufacturing: A Perspective from Pharmaceutical and Fine Chemicals ManufacturersOrganic Process Research and Development2011308
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitorAntimicrobial Agents and Chemotherapy2011304
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationAmerican Journal of Respiratory and Critical Care Medicine2011283
The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesisCancer Cell2011282